Skip to main content

Advertisement

Log in

Hashimoto’s Thyroiditis Does Not Affect Ultrasonographical, Cytological, and Histopathological Features in Patients with Papillary Thyroid Carcinoma

  • Published:
Endocrine Pathology Aims and scope Submit manuscript

Abstract

The association between papillary thyroid carcinoma (PTC) and Hashimoto’s thyroiditis (HT) is controversial. In this study, we aimed to compare preoperative thyroid functions, ultrasonography (US) features, fine-needle aspiration biopsy (FNAB) results, and histopathological characteristics of PTC in patients with and without HT. Data of 919 PTC patients were reviewed retrospectively. The diagnosis of HT was based on histopathological examination and patients were grouped as HT and non-HT. There were 1321 PTC lesions in 919 patients among which 317 (34.5 %) had coexistent HT. There were no significant differences in nodule volume, longitudinal diameter, texture, echogenicity, marginal regularity, presence of microcalcification and hypoechoic halo, and peripheral vascularization in patients with and without HT (p > 0.05, for all parameters). Macrocalcification was observed more frequently in the non-HT group (p = 0.021). FNAB results were similar in the two groups (p = 0.105). Distribution of variants, capsule invasion, vascular invasion, and extrathyroidal extension were observed with similar rates in the HT and non-HT groups. Lymph node metastasis was significantly higher in patients without HT (p = 0.012). Of the carcinomas, 66.1 % (n = 874) were papillary thyroid microcarcinoma (PTMC). Tumor size was lower in PTMC lesions coexistent with HT (p = 0.026). We observed lower rates of capsule invasion, extrathyroidal extension, and lymph node metastases in PTMC with HT compared to without HT (p = 0.007, p = 0.003, and p = 0.015, respectively). This study showed that US features, FNAB results, and histopathological findings of PTC lesions are not influenced by the presence of HT. However, PTMC seems to be related with less aggressive histopathological behavior in HT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Mazzaferri EL, Young RL (1981) Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients. Am J Med 70: 511–518

    Article  CAS  PubMed  Google Scholar 

  2. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985–1995 (1998) Cancer 83:2638–2648

    Article  CAS  PubMed  Google Scholar 

  3. Guarino V, Castellone MD, Avilla E, Melillo RM (2010) Thyroid cancer and inflammation. Mol Cell Endocrinol 321:94–102

    Article  CAS  PubMed  Google Scholar 

  4. Tamimi DM (2002) The association between chronic lymphocytic thyroiditis and thyroid tumors. Int J Surg Pathol 10:141–146

    Article  PubMed  Google Scholar 

  5. Schaffler A, Palitzsch KD, Seiffarth C, Höhne HM, Riedhammer FJ, Hofstädter F, Schölmerich J, Rüschoff J (1998) Coexistent thyroiditis is associated with lower tumour stage in thyroid carcinoma. Eur J Clin Invest 28:838–844

    Article  CAS  PubMed  Google Scholar 

  6. Antonaci A, Consorti F, Mardente S, Giovannone G (2009) Clinical and biological relationship between chronic lymphocytic thyroiditis and papillary thyroid carcinoma. Oncol Res 17:495–503

    Article  PubMed  Google Scholar 

  7. Wirtschafter A, Schmidt R, Rosen D, Kundu N, Santoro M, Fusco A, Multhaupt H, Atkins JP, Rosen MR, Keane WM, Rothstein JL (1997) Expression of the RET/PTC fusion gene as a marker for papillary carcinoma in Hashimoto’s thyroiditis. Laryngoscope 107:95–100

    Article  CAS  PubMed  Google Scholar 

  8. Cornetta AJ, Russell JP, Cunnane M, Keane WM, Rothstein JL (2002) Cyclooxygenase-2 expression in human thyroid carcinoma and Hashimoto’s thyroiditis. Laryngoscope 112:238–242

    Article  CAS  PubMed  Google Scholar 

  9. Matsubayashi S, Kawai K, Matsumoto Y, Mukuta T, Morita T, Hirai K, Matsuzuka F, Kakudoh K, Kuma K, Tmai H (1995) The correlation between papillary thyroid carcinoma and lymphocytic infiltration in the thyroid gland. J Clin Endocrinol Metab 80:3421–3424

    CAS  PubMed  Google Scholar 

  10. Loh KC, Greenspan FS, Dong F, Miller TR, Yeo PP (1999) Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 84:458–463

    Article  CAS  PubMed  Google Scholar 

  11. Singh B, Shaha AR, Trivedi H, Carew JF, Poluri A, Shah JP (1999) Coexistent Hashimoto’s thyroiditis with papillary thyroid carcinoma: impact on presentation, management, and outcome. Surgery 126:1070–1076

    Article  CAS  PubMed  Google Scholar 

  12. Del Rio P, Cataldo S, Sommaruga L, Concione L, Arcuri MF, Sianesi M (2008) The association between papillary carcinoma and chronic lymphocytic thyroiditis: does it modify the prognosis of cancer? Minerva Endocrinol 33:1–5.

    PubMed  Google Scholar 

  13. Jo VY, Stelow EB, Dustin SM, Hanley KZ (2010) Malignancy risk for fine-needle aspiration of thyroid lesions according to the Bethesda System for Reporting Thyroid Cytopathology. Am J Clin Pathol 134:450–456

    Article  PubMed  Google Scholar 

  14. Cibas ES, Ali SZ (2009) The Bethesda System for Reporting Thyroid Cytopathology. Thyroid 19:1159–1165

    Article  PubMed  Google Scholar 

  15. Weetman AP (2004) Cellular immune responses in autoimmune thyroid disease. Clin Endocrinol 61:405–413

    Article  CAS  Google Scholar 

  16. Cipolla C, Sandonato L, Graceffa G, Fricano S, Torcivia A, Vieni S, Latteri S, Latteri MA (2005) Hashimoto thyroiditis coexistent with papillary carcinoma. Am Surg 71:874–878

    PubMed  Google Scholar 

  17. Larson SD, Jackson L, Riall T, Uchida T, Thomas RP, Qiu S, Evers BM (2007) Increased incidence of well-differentiated thyroid cancer associated with Hashimoto’s thyroiditis and the role of the PI3K/AKT pathway. J Am Coll Surg 204:764–775

    Article  PubMed Central  PubMed  Google Scholar 

  18. Erdogan M, Erdem N, Cetinkalp S, Ozgen AG, Saygılı F, Yilmaz C, Tuzun M, Kabalak T (2009) Demographic, clinical, laboratory, ultrasonographic, and cytological features of patients with Hashimoto’s thyroiditis: a result of a university hospital of 769 patients in Turkey. Endocrine 36:486–490

    Article  CAS  PubMed  Google Scholar 

  19. Repplinger D, Bargren A, Zhang YW, Adler JT, Haymart M, Chen H (2008) Is Hashimoto’s thyroiditis a risk factor for papillary thyroid cancer. J Surg Res 150:49–52

    Article  PubMed Central  PubMed  Google Scholar 

  20. Anil C, Goksel S, Gursoy A (2010) Hashimoto’s thyroiditis is not associated with increased risk of thyroid cancer in patients with thyroid nodules: a single-center prospective study. Thyroid 20:601–606

    Article  PubMed  Google Scholar 

  21. Matesa-Anic’ D, Matesa N, Dabelic’ N, Kusic’ Z (2009) Coexistence of papillary carcinoma and Hashimoto’s thyroiditis. Acta Clin Croat 48:9–12.

    Google Scholar 

  22. Bradly D, Reddy V, Prinz RA, Gattuso P (2009) Incidental papillary carcinoma in patients treated surgically for benign thyroid diseases. Surgery 146:1099–1104

    Article  PubMed  Google Scholar 

  23. Kwak HY, Chae BJ, eom YH, Hong YR, Seo JB, Lee SH, Song BJ, Jung SS, Bae JS (2015) Does papillary thyroid carcinoma have a better prognosis with or without Hashimoto thyroiditis? Int J Clin Oncol 20:463–473

    Article  CAS  PubMed  Google Scholar 

  24. Lun Y, Wu X, Xia Q, Han Y, Zhang X, Liu Z, Wang F, Duan Z, Xin S, Zhang J (2013) Hashimoto’s thyroiditis as a risk factor of papillary thyroid cancer may improve cancer prognosis. Otolaryngol Head Neck Surg 148:396–402

    Article  PubMed  Google Scholar 

  25. Tae HJ, Lim DJ, Baek KH, Park WC, Lee YS, Choi JE, Lee JM, Kang MI, Cha BY, Son HY, Lee KW, Kang SK (2007) Diagnostic value of ultrasonography to distinguish between benign and malignant lesions in the management of thyroid nodules. Thyroid 17: 461–466

    Article  PubMed  Google Scholar 

  26. Solbiati L, Livraghi T, Ballarati E, et al. (1995) Thyroid gland. In: Solbiati L, Rizzatto G. Ultrasound of Superficial Structure: London: Churchill, Livingstone, 45: 85, 1995 SA ed. Thyroid disease: Endocrinology, Surgery, Nuclear Medicine and Radiology Lippincott-Raven, Philadelphia, 65–104

  27. LiVolsi VA (1997) Pathology of thyroid disease. In: Thyroid Disease: Endocrinology, Surgery, Nuclear Medicine and Radiology, Falk SA, Eds. Lippincott-Raven, Philadelphia, 65–104

    Google Scholar 

  28. Yeh HC, Futterweit W, Gilbert P (1996) Micronodulation: ultrasonographic sign of Hashimoto Thyroiditis. J Ultrasound Med 15: 813–819

    CAS  PubMed  Google Scholar 

  29. Trimboli P, Nasrollah N, Amendola S, Rossi F, Ramacciato G, Romanelli F, Aurella P, Crescenzi A, Laurenti O, Condorelli E, Ventura C, Valabrega S (2012) Should we use ultrasound features associated with papillary thyroid cancer in diagnosing medullary thyroid cancer? Endocr J 59:503–508

    Article  PubMed  Google Scholar 

  30. Das DK, Sheikh ZA, George SS, Al-Baquer T, Francis IM (2008) Papillary thyroid carcinoma: evidence for intracytoplasmic formation of precursor substance for calcification and its release from well-preserved neoplastic cells. Diagn Cytopathol 36:809–812

    Article  PubMed  Google Scholar 

  31. Kim EK, Parl CS, Chung WY, Oh KK, Kim DI, Lee JT, Yoo HS (2002) New sonographic criteria for recommends fine-needle aspiration biopsy of nonpalpable solid nodule of the thyroid. A JR Am J Roentgenol 178:687–691

    Article  Google Scholar 

  32. Ohmori N, Miyakawa M, ohmori K, Takano K (2007) Ultrasonographic findings of papillary thyroid carcinoma with Hashimoto’s thyroiditis. Intern Med 46:547–550

    Article  PubMed  Google Scholar 

  33. Nguyen GK, Ginsberg J, Crockford PM, Villanueva RR (1997) Hashimoto’s thyroiditis: cytodiagnostic accuracy and pitfalls. Diagn Cytopathol 16:531–536.

    Article  CAS  PubMed  Google Scholar 

  34. Ravinsky E, Safneck JR (1988) Differentiation of Hashimoto’s thyroiditis from thyroid neoplasms in fine needle aspirates. Acta Cytol 32:854–861

    CAS  PubMed  Google Scholar 

  35. Kumarasinghe MP, De Silva S (1999) Pitfalls in cytological diagnosis of autoimmune thyroiditis. Pathology 31:1–7

    Article  CAS  PubMed  Google Scholar 

  36. Spencer CA (2011) Clinical review: Clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC). J Clin Endocrinol Metab 96:3615–3627

    Article  CAS  PubMed  Google Scholar 

  37. Vasileiadis I, Boutzios G, Charitoudis G, Koukoulioti E, Karatzas T (2014) Thyroglobulin antibodies could be a potential predictive marker for papillary thyroid carcinoma. Ann Surg Oncol 21:2725–2732

    Article  PubMed  Google Scholar 

  38. Paparodis R, Imam S, Todorova-Koteva K, Staii A, Jaume JC (2014) Hashimoto’s thyroiditis pathology and risk for thyroid cancer. Thyroid 24:1107–1114

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  39. Yoon YH, Kim HJ, Lee JW, Kim JM, Koo BS (2012) The clinicopathologic differences in papillary thyroid carcinoma with or without co-existing chronic lymphocytic thyroiditis. Eur Arch Otorhinoloaryngol 269:1013–1017

    Article  Google Scholar 

  40. Lee JH, Kim Y, Choi JW, Kim YS (2013) The association between papillary thyroid carcinoma and histologically proven Hashimoto’s thyroiditis: a meta-analysis. Eur J Endocrinol 168:343–349

    Article  CAS  PubMed  Google Scholar 

  41. Singh S, Singh A, Khanna AK (2012) Thyroid incidentalomas. Indian J Surg Oncol 3:173–181

    Article  PubMed Central  PubMed  Google Scholar 

  42. Roti E, delgi Uberti EC, Bondanelli M, Braverman LE (2008) Thyroid papillary microcarcinoma: a descriptive and meta-analysis study. Eur J Endocrinol 159:659–673

    Article  CAS  PubMed  Google Scholar 

  43. Noguchi S, Yamashita H, Uchino S, Watanabe S (2008) Papillary microcarcinoma. World J Surg 32:747–753

    Article  PubMed Central  PubMed  Google Scholar 

  44. Lee HS, Park HS, Kim SW, Choi G, Park HS, Hong JC, Lee SG, Baek SM, Lee KD (2013) Clinical characteristics of papillary thyroid microcarcinoma less than or equal to 5 mm on ultrasonography. Eur Arch otorhinolaryngol 270:2969–2974

    Article  PubMed  Google Scholar 

  45. Page C, Biet A, Boute P, Cuvelier P, Strunski V (2009) ‘Aggressive papillary’ thyroid microcarcinoma. Eur Arch Otorhinolaryngol 266:1959–1963

    Article  PubMed  Google Scholar 

  46. Ross DS, Litofsky D, Ain KB, Bigos T, Brierley JD, Cooper DS, Haugen BR, Jonklaas J, Ladenson PW, Magner J, et al. (2009) Recurrence after treatment of micropapillary thyroid cancer. Thyroid 19:1043–1048

    Article  PubMed  Google Scholar 

  47. Mantinan B, Rego-Iraeta A, Larranaga A, Fluiters E, Sanchez-Sobrino P, Garcia-Mayor RV (2012) Factors influencing the outcome of patients with incidental papillary thyroid microcarcinoma. J Thyroid Res 2012:469397

    Article  PubMed Central  PubMed  Google Scholar 

  48. Gallo M, Pesenti M, Valcavi R (2003) Ultrasound thyroid nodule measurement: the “gold standard” and its limitations in clinical decision making. Endocr Pract 9:194–199

    Article  PubMed  Google Scholar 

  49. Hegedüs L (1990) Thyroid size determined by ultrasound. Influence of physiological factors and non-thyroidal disease. Dan Med Bull 37:249–263

    PubMed  Google Scholar 

  50. Knudsen N, Bols B, Bülow I, Jørgensen T, Perrild H, Ovesen L, Laurberg P (1999) Validation of ultrasonography of the thyroid gland for epidemiological purposes. Thyroid 9:1069–1074

    Article  CAS  PubMed  Google Scholar 

  51. Baloch ZW, LiVolsi VA (1999) Post fine-needle aspiration histologic alterations of thyroid revisited. Am J Clin Pathol 112:311–316

    CAS  PubMed  Google Scholar 

  52. Yoon YH, Kwon KR, Kwak SY, Ryu KA, Choi B, Kim JM, Koo BS (2014) Tumor size measured by preoperative ultrasonography and postoperative pathologic examination in papillary thyroid carcinoma: relative differences according to size, calcification and coexisting thyroiditis. Eur Arch Otorhinolaryngol 271:1235–1239

    Article  PubMed  Google Scholar 

  53. Bachar G, Buda I, Cohen M, Hadar T, Hilly O, Schwartz N, Shpitzer T, Segal K (2013) Size discrepancy between sonographic and pathological evaluation of solitary papillary thyroid carcinoma. Eur J Radiol 82: 1899–1903

    Article  PubMed  Google Scholar 

  54. Xing M, Clark D, Guan H, Ji M, Dackiw A, Carson KA, Kim M, Tufaro A, Ladenson P, Zeiger M, Tufano R (2009) BRAF mutation testing of thyroid fine-needle aspiration biopsy specimens for preoperative risk stratification in papillary thyroid cancer. J Clin Oncol 27:2977–2982

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  55. Howell GM, Nikiforova MN, Carty SE, Armstrong MJ, Hodak SP, Stang MT, McCoy KL, Nikiforov YE, Yip L (2013) BRAF V600E mutation independently predicts central compartment lymph node metastasis in patients with papillary thyroid cancer. Ann Surg Oncol 20:47–52

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Husniye Baser.

Ethics declarations

Local ethical committee approval was obtained in accordance with the ethical standards of Helsinki Declaration.

Conflict of interest

The authors declare that they have no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Baser, H., Ozdemir, D., Cuhaci, N. et al. Hashimoto’s Thyroiditis Does Not Affect Ultrasonographical, Cytological, and Histopathological Features in Patients with Papillary Thyroid Carcinoma. Endocr Pathol 26, 356–364 (2015). https://doi.org/10.1007/s12022-015-9401-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12022-015-9401-8

Keywords

Navigation